Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 2
1997 2
2001 3
2002 2
2003 2
2004 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 3
2012 1
2013 1
2018 1
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Women's Health and Gender-Specific Considerations.
Huffstetler AN, Ramirez SI, Dalrymple SN, Mendez Miller MH. Huffstetler AN, et al. Prim Care. 2021 Mar;48(1):117-129. doi: 10.1016/j.pop.2020.09.008. Epub 2020 Nov 26. Prim Care. 2021. PMID: 33516417 Review.
Topics that should be discussed include menstrual practices, contraception and beliefs about family planning, prior screening for preventable diseases, pregnancies and experiences with childbirth, sexual assault and trauma, and history of traditional practices, including f …
Topics that should be discussed include menstrual practices, contraception and beliefs about family planning, prior screening for preventabl …
p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease.
Dalrymple SA. Dalrymple SA. J Mol Neurosci. 2002 Dec;19(3):295-9. doi: 10.1385/JMN:19:3:295. J Mol Neurosci. 2002. PMID: 12540055 Review.
The characteristic pathological hallmarks of Alzheimer's disease (AD) include neuritic plaques, neurofibrillary tangles, and inflammatory changes. Current therapies, such as molecules that target enhancing cholinergic activity, can improve cognitive function in the short t …
The characteristic pathological hallmarks of Alzheimer's disease (AD) include neuritic plaques, neurofibrillary tangles, and inflamma …
Targeting B cells for the treatment of rheumatoid arthritis.
Oligino TJ, Dalrymple SA. Oligino TJ, et al. Arthritis Res Ther. 2003;5 Suppl 4(Suppl 4):S7-11. doi: 10.1186/ar1006. Epub 2003 Oct 2. Arthritis Res Ther. 2003. PMID: 15180891 Free PMC article. Review.
However, recent clinical trial data indicating that depletion of B cells in RA patients is of therapeutic benefit has validated the importance of this cell type in the pathogenesis of the disease. Elucidation of the molecular basis of B cell development and activation has …
However, recent clinical trial data indicating that depletion of B cells in RA patients is of therapeutic benefit has validated the importan …
The cytokine stew and innate resistance to L. monocytogenes.
Mocci S, Dalrymple SA, Nishinakamura R, Murray R. Mocci S, et al. Immunol Rev. 1997 Aug;158:107-14. doi: 10.1111/j.1600-065x.1997.tb00996.x. Immunol Rev. 1997. PMID: 9314078 Review.
One of the many cytokines implicated in resistance to L. monocytogenes infection is interleukin (IL)-6, a molecule associated with diverse infectious and pathophysiological disease states. This review concentrates on various cytokines (IL-1, TNF alpha, IFN-gamma, IL-12, IL …
One of the many cytokines implicated in resistance to L. monocytogenes infection is interleukin (IL)-6, a molecule associated with diverse i …
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling.
Patterson JC, Varkaris A, Croucher PJP, Ridinger M, Dalrymple S, Nouri M, Xie F, Varmeh S, Jonas O, Whitman MA, Chen S, Rashed S, Makusha L, Luo J, Isaacs JT, Erlander MG, Einstein DJ, Balk SP, Yaffe MB. Patterson JC, et al. Cancer Res. 2023 Jan 18;83(2):219-238. doi: 10.1158/0008-5472.CAN-22-1533. Cancer Res. 2023. PMID: 36413141 Free PMC article.
Abiraterone is a standard treatment for metastatic castrate-resistant prostate cancer (mCRPC) that slows disease progression by abrogating androgen synthesis and antagonizing the androgen receptor (AR). ...
Abiraterone is a standard treatment for metastatic castrate-resistant prostate cancer (mCRPC) that slows disease progression by abrog …
Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D, Piccorelli AV, Hannah WB, Dalrymple SN, Pace RG, Durie PR, Ling SC, Knowles MR, Stonebraker JR. Polineni D, et al. PLoS One. 2018 Oct 11;13(10):e0205257. doi: 10.1371/journal.pone.0205257. eCollection 2018. PLoS One. 2018. PMID: 30307979 Free PMC article.
Previous reports of lung function in cystic fibrosis (CF) patients with liver disease have shown worse, similar, or even better forced expiratory volume in 1 second (FEV1), compared to CF patients without liver disease. Varying definitions of CF liver disease
Previous reports of lung function in cystic fibrosis (CF) patients with liver disease have shown worse, similar, or even better force …
Crystallization and preliminary X-ray studies of the N-domain of the Wilson disease associated protein.
Liu L, O'Grady C, Dalrymple SA, Prasad L, Dmitriev OY, Delbaere LT. Liu L, et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 1;65(Pt 6):621-4. doi: 10.1107/S1744309109017023. Epub 2009 May 22. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009. PMID: 19478447 Free PMC article.
Wilson disease associated protein (ATP7B) is essential for copper transport in human cells. Mutations that affect ATP7B function result in Wilson's disease, a chronic copper toxicosis. Disease-causing mutations within the N-domain of ATP7B (WND) are known to …
Wilson disease associated protein (ATP7B) is essential for copper transport in human cells. Mutations that affect ATP7B function resu …
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.
Pan Z, Scheerens H, Li SJ, Schultz BE, Sprengeler PA, Burrill LC, Mendonca RV, Sweeney MD, Scott KC, Grothaus PG, Jeffery DA, Spoerke JM, Honigberg LA, Young PR, Dalrymple SA, Palmer JT. Pan Z, et al. ChemMedChem. 2007 Jan;2(1):58-61. doi: 10.1002/cmdc.200600221. ChemMedChem. 2007. PMID: 17154430 No abstract available.
28 results